peripheral facial paralysis G51.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Facial nerve palsy diagnosed by a doctor and treated at Jena University Hospital Patients who developed facial nerve palsy before the age of 18 - Written consent of the patient or legal guardian (for patients under the age of 18) to participate in the study
Exclusion criteria
Exclusion criteria: - Lack of written consent from adult patients or legal guardians to perform the examination - Patients who were at least 18 years old when the facial nerve palsy occurred
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this study is to find out whether pediatric facial nerve palsy regresses completely and without side effects or whether any effects that may occur, such as asymmetries in the face or synkinesia, have so far been overlooked. This is determined by evaluating the questionnaires and by analyzing the video recordings via eFaCE and Sunnybrook. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective is to determine whether asymmetries or side effects occurred less frequently during early treatment with prednisolone and whether it can be concluded from this that this therapy is also effective in children. The patients are first differentiated according to whether they received prednisolone as therapy or not. These groups are then compared with each other in order to determine any differences in the outcome of the patients. | — |
Countries
Germany
Contacts
Universitätsklinikum Jena, Klinik und Poliklinik für Hals-. Nasen- und Ohrenheilkunde